BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 36401787)

  • 21. Novel treatments for melanoma brain metastases.
    Kenchappa RS; Tran N; Rao NG; Smalley KS; Gibney GT; Sondak VK; Forsyth PA
    Cancer Control; 2013 Oct; 20(4):298-306. PubMed ID: 24077406
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Genome-wide copy number variations as molecular diagnostic tool for cutaneous intermediate melanocytic lesions: a systematic review and individual patient data meta-analysis.
    Ebbelaar CF; Jansen AML; Bloem LT; Blokx WAM
    Virchows Arch; 2021 Oct; 479(4):773-783. PubMed ID: 33851238
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Childhood-Onset Schizophrenia: A Systematic Overview of Its Genetic Heterogeneity From Classical Studies to the Genomic Era.
    Fernandez A; Drozd MM; Thümmler S; Dor E; Capovilla M; Askenazy F; Bardoni B
    Front Genet; 2019; 10():1137. PubMed ID: 31921276
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comprehensive molecular biomarker identification in breast cancer brain metastases.
    Schulten HJ; Bangash M; Karim S; Dallol A; Hussein D; Merdad A; Al-Thoubaity FK; Al-Maghrabi J; Jamal A; Al-Ghamdi F; Choudhry H; Baeesa SS; Chaudhary AG; Al-Qahtani MH
    J Transl Med; 2017 Dec; 15(1):269. PubMed ID: 29287594
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Accuracy of analysis of cfDNA for detection of single nucleotide variants and copy number variants in breast cancer.
    Yang X; Zhang K; Zhang C; Peng R; Sun C
    BMC Cancer; 2019 May; 19(1):465. PubMed ID: 31101027
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Whole genome sequencing of 35 individuals provides insights into the genetic architecture of Korean population.
    Zhang W; Meehan J; Su Z; Ng HW; Shu M; Luo H; Ge W; Perkins R; Tong W; Hong H
    BMC Bioinformatics; 2014; 15 Suppl 11(Suppl 11):S6. PubMed ID: 25350283
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Integration of genomic copy number variations and chemotherapy-response biomarkers in pediatric sarcoma.
    Cheng L; Pandya PH; Liu E; Chandra P; Wang L; Murray ME; Carter J; Ferguson M; Saadatzadeh MR; Bijangi-Visheshsaraei K; Marshall M; Li L; Pollok KE; Renbarger JL
    BMC Med Genomics; 2019 Jan; 12(Suppl 1):23. PubMed ID: 30704460
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Meta-Analysis and Systematic Review of the Genomics of Mucosal Melanoma.
    Broit N; Johansson PA; Rodgers CB; Walpole ST; Newell F; Hayward NK; Pritchard AL
    Mol Cancer Res; 2021 Jun; 19(6):991-1004. PubMed ID: 33707307
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The role of combined SNV and CNV burden in patients with distal symmetric polyneuropathy.
    Pehlivan D; Beck CR; Okamoto Y; Harel T; Akdemir ZH; Jhangiani SN; Withers MA; Goksungur MT; Carvalho CM; Czesnik D; Gonzaga-Jauregui C; Wiszniewski W; Muzny DM; Gibbs RA; Rautenstrauss B; Sereda MW; Lupski JR
    Genet Med; 2016 May; 18(5):443-51. PubMed ID: 26378787
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Identification of novel candidate disease genes from de novo exonic copy number variants.
    Gambin T; Yuan B; Bi W; Liu P; Rosenfeld JA; Coban-Akdemir Z; Pursley AN; Nagamani SCS; Marom R; Golla S; Dengle L; Petrie HG; Matalon R; Emrick L; Proud MB; Treadwell-Deering D; Chao HT; Koillinen H; Brown C; Urraca N; Mostafavi R; Bernes S; Roeder ER; Nugent KM; Bader PI; Bellus G; Cummings M; Northrup H; Ashfaq M; Westman R; Wildin R; Beck AE; Immken L; Elton L; Varghese S; Buchanan E; Faivre L; Lefebvre M; Schaaf CP; Walkiewicz M; Yang Y; Kang SL; Lalani SR; Bacino CA; Beaudet AL; Breman AM; Smith JL; Cheung SW; Lupski JR; Patel A; Shaw CA; Stankiewicz P
    Genome Med; 2017 Sep; 9(1):83. PubMed ID: 28934986
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Double hits in schizophrenia.
    Vorstman JAS; Olde Loohuis LM; ; Kahn RS; Ophoff RA;
    Hum Mol Genet; 2018 Aug; 27(15):2755-2761. PubMed ID: 29767709
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Simultaneous detection of target CNVs and SNVs of thalassemia by multiplex PCR and next‑generation sequencing.
    Fan DM; Yang X; Huang LM; Ouyang GJ; Yang XX; Li M
    Mol Med Rep; 2019 Apr; 19(4):2837-2848. PubMed ID: 30720081
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Genomics of Clear-cell Renal Cell Carcinoma: A Systematic Review and Meta-analysis.
    Bui TO; Dao VT; Nguyen VT; Feugeas JP; Pamoukdjian F; Bousquet G
    Eur Urol; 2022 Apr; 81(4):349-361. PubMed ID: 34991918
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Applications of next-generation sequencing analysis for the detection of hepatocellular carcinoma-associated hepatitis B virus mutations.
    Wu IC; Liu WC; Chang TT
    J Biomed Sci; 2018 Jun; 25(1):51. PubMed ID: 29859540
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Genes associated with increased brain metastasis risk in non-small cell lung cancer: Comprehensive genomic profiling of 61 resected brain metastases versus primary non-small cell lung cancer (Guangdong Association Study of Thoracic Oncology 1036).
    Wang H; Ou Q; Li D; Qin T; Bao H; Hou X; Wang K; Wang F; Deng Q; Liang J; Zheng W; Wu X; Wang X; Shao YW; Mou Y; Chen L
    Cancer; 2019 Oct; 125(20):3535-3544. PubMed ID: 31287555
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Different Gene Mutation Spectrum of the Paired CSF and Plasma Samples in Lung Adenocarcinoma with Leptomeningeal Metastases: the Liquid Biopsy Based on Circulating Tumor DNA].
    Li H; Xie Y; Lin Y; Yu T; Yin Z
    Zhongguo Fei Ai Za Zhi; 2020 Aug; 23(8):646-654. PubMed ID: 32838487
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A Retrospective Evaluation of Vemurafenib as Treatment for BRAF-Mutant Melanoma Brain Metastases.
    Harding JJ; Catalanotti F; Munhoz RR; Cheng DT; Yaqubie A; Kelly N; McDermott GC; Kersellius R; Merghoub T; Lacouture ME; Carvajal RD; Panageas KS; Berger MF; Rosen N; Solit DB; Chapman PB
    Oncologist; 2015 Jul; 20(7):789-97. PubMed ID: 25956405
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Longitudinal therapy monitoring of ALK-positive lung cancer by combined copy number and targeted mutation profiling of cell-free DNA.
    Dietz S; Christopoulos P; Yuan Z; Angeles AK; Gu L; Volckmar AL; Ogrodnik SJ; Janke F; Fratte CD; Zemojtel T; Schneider MA; Kazdal D; Endris V; Meister M; Muley T; Cecchin E; Reck M; Schlesner M; Thomas M; Stenzinger A; Sültmann H
    EBioMedicine; 2020 Dec; 62():103103. PubMed ID: 33161228
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Whole exome sequencing in recurrent early pregnancy loss.
    Qiao Y; Wen J; Tang F; Martell S; Shomer N; Leung PC; Stephenson MD; Rajcan-Separovic E
    Mol Hum Reprod; 2016 May; 22(5):364-72. PubMed ID: 26826164
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.